2013;11(10):1337-1347. The long-awaited results of the Future Revascularization Evaluation in Patients with Diabetes Mellitus: Optimal Management of Multi-vessel Disease (FREEDOM) trial ...
Low-dose methotrexate was not clinically effective for lowering blood pressure among patients without rheumatic disease who have cardiovascular risk factors.
The 2-year follow-up data from the FAME (Fractional Flow Reserve versus Angiography for Multivessel Evaluation) trial 1 show that patients with coronary artery disease (CAD) undergoing ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback